Challenges in modelling the proportion of undiagnosed HIV infections in Sweden by Andersson, E et al.
1www.eurosurveillance.org
Research
Challenges in modelling the proportion of undiagnosed 
HIV infections in Sweden
Emmi Andersson1,2, Fumiyo Nakagawa³, Ard van Sighem4, Maria Axelsson⁵, Andrew N Phillips³, Anders Sönnerborg1,2,6,7, Jan 
Albert2,8
1. Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
2. Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
3. Institute for Global Health, University College London, London, United Kingdom
4. Stichting HIV Monitoring, Amsterdam, the Netherlands
5. Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden
6. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
7. Unit of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
8. Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
Correspondence: Emmi Andersson (emmi.andersson@ki.se)
Citation style for this article: 
Andersson Emmi, Nakagawa Fumiyo, van Sighem Ard, Axelsson Maria, Phillips Andrew N, Sönnerborg Anders, Albert Jan. Challenges in modelling the proportion of 
undiagnosed HIV infections in Sweden. Euro Surveill. 2019;24(14):pii=1800203. https://doi.org/10.2807/1560-7917.ES.2019.24.14.1800203
Article submitted on 18 Apr 2018 / accepted on 28 Nov 2018 / published on 04 Apr 2019
Background: Sweden has a low HIV prevalence. 
However, among new HIV diagnoses in 2016, the pro-
portion of late presenters and migrants was high (59% 
and 81%, respectively). This poses challenges in esti-
mating the proportion of undiagnosed persons living 
with HIV (PLHIV). Aim: To estimate the proportion of 
undiagnosed PLHIV in Sweden comparing two models 
with different demands on data availability and mod-
elling expertise. Methods: An individual-based sto-
chastic simulation model of HIV positive populations 
(SSOPHIE) and the incidence method of the European 
Centre for Disease Prevention and Control (ECDC) HIV 
Modelling Tool were applied to clinical, surveillance 
and migration data from Sweden 1980–2016. Results:
SSOPHIE estimated that the proportion of undiagnosed 
PLHIV in 2013 was 26% (n = 2,100; 90% plausibility 
range (PR): 900–5,000) for all PLHIV, 17% (n = 600; 
90% PR: 100–2,000) for men who have sex with men 
(MSM), 35% in male (n = 300; 90% PR: 200–700) and 
34% in female (n = 400; 90% PR: 200–800) migrants 
from sub-Saharan Africa (SSA). The estimates for the 
ECDC model in 2013 were 21% (n = 2,013; 95% con-
fidence interval (CI): 1,831–2,189) for all PLHIV, 15% 
(n = 369; 95% CI: 299–434) for MSM and 21% (n = 530; 
95% CI: 436–632) for migrants from SSA. Conclusions:
The proportion of undiagnosed PLHIV in Sweden is 
uncertain. SSOPHIE estimates had wide PR. The ECDC 
model estimates were unreliable because migration 
was not accounted for. Better migration data and esti-
mation methods are required to obtain reliable esti-
mates of proportions of undiagnosed PLHIV in similar 
settings.
Introduction
Estimating the number of undiagnosed persons liv-
ing with HIV (PLHIV) is crucial to describe the HIV care 
continuum and to address the Joint United Nations 
Programme on HIV/AIDS (UNAIDS) 90–90–90 target 
[1]. This requires reliable data on the number of undi-
agnosed and diagnosed PLHIV, the proportion of diag-
nosed PLHIV receiving antiretroviral therapy (ART) and 
the proportion of those receiving ART who are virally 
suppressed [1]. Unlike the other parameters in the HIV 
care continuum, the undiagnosed proportion of PLHIV 
cannot be directly monitored and must be estimated.
Sweden has a low prevalence of diagnosed PLHIV 
(0.07% (data not shown) compared to 0.4% in adults 
in the European World Health Organization (WHO) 
Region [2]) and a low incidence of new HIV diagno-
ses, with 430 new cases reported within the national 
surveillance programme in 2016. The number of new 
cases with reported transmission within Sweden has 
decreased and has remained below 100 cases per 
year between 2013 and 2017 [3]. Thus, most HIV infec-
tions diagnosed in Sweden are reported to have been 
acquired abroad. A large proportion of new HIV diag-
noses in Sweden occur in migrants with 81% in 2016 
(77%, 72%, 80%, 84% and 80% between 2011 and 
2015, respectively) according to data from the Public 
Health Agency of Sweden (data not shown). Migrants 
from sub-Saharan Africa (SSA) constitute the largest 
group (38% of all new infections in 2016) and most 
of them are reported to have acquired their HIV infec-
tion in their country of origin. However, a recent study 
indicates that doctors underestimated the occurrence 
of transmissions after arrival to Sweden. Thus, a CD4+ 
T-cell decline trajectory model applied to migrants 
diagnosed with HIV in Sweden 1983–2013 estimated 
that 19% of migrants were infected post-migration, 
rather than 12% as officially reported [4]. Furthermore, 
between 2009 and 2012, 58% of individuals diagnosed 
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with HIV in Sweden were late presenters [5], as defined 
by a CD4 + T-lymphocyte (CD4+) count < 350 cells/µl at 
diagnosis [6]. Late presentation was associated with 
origin in SSA, eastern Europe, Asia and the Pacific 
region [5]. Data from the National Quality Registry for 
HIV (InfCareHIV) [7] Sweden shows that late presenta-
tion still is common (59% in 2016) (data not shown).
In Sweden, most parameters of the HIV care continuum 
are well documented in InfCareHIV, which has had 
national coverage since 2008. Sweden was reported to 
be the first country to achieve the UNAIDS 90–90–90 
target [8] but the estimate of the proportion of undiag-
nosed PLHIV is uncertain; as in many other European 
countries [9]. The proportion of undiagnosed PLHIV 
in Sweden was estimated to be 12–20% in 2006 by 
Hamers et al.  [10] but no estimates have been pub-
lished since.
Access to high quality surveillance data combined with 
near complete coverage of diagnosed individuals with 
HIV in InfCareHIV since 2008, as well as good coverage 
of entry of CD4+ cell counts at diagnosis (95% in 2013), 
country of origin (99% in 2013) and transmission route 
(96% in 2013) are good starting points for estimating 
undiagnosed individuals with HIV in Sweden.
We evaluated two models with different requirements 
on data availability and modelling expertise to esti-
mate the proportion of undiagnosed PLHIV in Sweden. 
Migration may bias estimates of undiagnosed HIV infec-
tions, because HIV-positive migrants should only be 
counted as undiagnosed in Sweden after their arrival 
to the country. The individual based stochastic simu-
lation model of HIV positive populations (SSOPHIE) 
[11-13] specifically accounts for both in-country infec-
tions and infections likely to have occurred abroad, 
but it is labour and computing intensive. The incidence 
method in the HIV Modelling Tool provided by the 
European Centre for Disease Prevention and Control 
(ECDC) [14,15] was developed to use routinely collected 
HIV surveillance data but does not take migration 
into account. We wanted to compare these available 
models to see how they performed on data from the 
Swedish HIV epidemic. Both models produce estimates 
of several stages of the HIV care continuum but in this 
analysis, we only focus on estimating the proportion of 
undiagnosed PLHIV in Sweden.
Methods
Data sources
InfCareHIV Sweden is a national quality assurance 
registry, clinical decision tool and research database. 
It has full national coverage since 2008 and covers 
the major cities including Stockholm, Gothenburg and 
Malmö since the 1980s. Clinical, epidemiological and 
laboratory data on all registered patients with an HIV 
diagnosis in Sweden are entered and a well-structured 
system for quality control ensures data reliability 
[4,16]. As at 1 June 2014, the date of data extraction 
used for the SSOPHIE modelling, 9,647 patients were 
registered in InfCareHIV Sweden. Complementary data 
extraction for the ECDC Modelling Tool was carried out 
on 13 March 2017 at which point 10,858 patients were 
registered. This extraction consisted of data for the 
years 2014–16 and HIV diagnoses within CD4+ count 
strata as explained in  Table 1. Only accumulated data 
on patient populations were extracted and no patient 
identifiers were used.
Table 1
Data items and sources to inform the ECDC HIV Modelling Tool
Data item (per year) Data source 1 Year Data source 2 Year
Number of HIV-1 diagnoses Public Health Agency of Sweden 1984–1995 InfCareHIV 1996–2016
Number of AIDS diagnoses Public Health Agency of Sweden 1983–2008 InfCareHIV 2009–2016
Number of simultaneous HIV/AIDS diagnoses Public Health Agency of Sweden 1983–2002 InfCareHIV 2003–2016
Number of deaths in HIV-1 infecteda Public Health Agency of Sweden 1983–1994 InfCareHIV 1995–2016
Number of HIV-1 diagnoses with CD4+ ≥ 500 cells/μl and no 
concurrent AIDS diagnosis InfCareHIV 1983–2016
Number of HIV diagnoses with CD4+ 350–499 cells/μl and no 
concurrent AIDS diagnosis InfCareHIV 1983–2016
Number of HIV diagnoses with CD4+ 200–349 cells/μl and no 
concurrent AIDS diagnosis InfCareHIV 1983–2016
Number of HIV diagnoses with CD4+ < 200 cells/μl and no 
concurrent AIDS diagnosis InfCareHIV 1983–2016
AIDS: acquired immunodeficiency syndrome; ECDC: European Centre for Disease Prevention and Control; InfCareHIV: National Quality Registry 
for HIV.
aFor heterosexual migrants from sub-Sahara, data source 1 covered 1988–2006 and data source 2 covered 2007–13.
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Since 1985, all HIV cases in Sweden are anonymously 
reported to the Public Health Agency of Sweden by 
the clinical doctor and the clinical laboratory that con-
firmed HIV under the Communicable Diseases Act [17]. 
From 1983 until 2005 reporting of acquired immuno-
deficiency syndrome (AIDS) was mandatory. Records 
of the number of HIV diagnoses, AIDS diagnoses and 
deaths per year within each transmission group were 
extracted from 1980 until 2013.
Data on general migration from SSA were used in 
SSOPHIE. These data were based on the number of per-
mits to stay in Sweden granted to persons born in SSA 
annually 1980–2014 as recorded by Statistics Sweden 
([18] and personal communication Lo Mildh, Statistics 
Sweden, 30 October 2015). These data were used 
because both the InfCareHIV database and the Public 
Health Agency of Sweden have incomplete records 
regarding when foreign-born HIV-positive persons first 
arrived in Sweden.
HIV type 2 represents < 0.5% of all HIV infections in 
Sweden, due to this we focused on HIV type 1, hereaf-
ter referred to as HIV.
Ethical approval
Ethical permit 532–11 with amendment T996–11 from 
the Regional Ethical Review Board in Gothenburg cov-
ers this study.
Data items and model populations
The data used by the models to inform estimates of 
undiagnosed infection were obtained from InfCareHIV 
database and the Public Health Agency of Sweden. For 
each data item, the coverage and data quality for the 
two sources was assessed over the study period and 
the source with the best coverage was chosen. For case 
reporting national surveillance data was used from the 
beginning of the epidemic until the mid-1990s and 
InfCareHIV data thereafter. CD4+ cell counts at diag-
nosis were extracted from InfCareHIV. A slight under-
reporting of AIDS cases is assumed after 2005 and 
compensated for by 15% in SSOPHIE. The data items 
and their sources are presented in Table 2 for SSOPHIE 
and Table 1 for the ECDC Modelling Tool.
The continuum of HIV care was monitored using data 
from the InfCareHIV database; figures on linkage to 
care, retention in care and retention on ART from 2013 
was > 99%, > 99% and > 98% respectively. Of patients 
retained in care, 98.5% started ART within a year if eli-
gible according to the national treatment guidelines at 
Table 2
Data items and sources to inform SSOPHIE
Data item (per year) Data source 1 Year Data source 2 Year
Number of HIV-1 diagnosesa Public Health Agency of Sweden 1980–1995 InfCareHIV 1996–2013
Number of AIDS diagnosesb Public Health Agency of Sweden 1980–2008 InfCareHIV 2009–2013
Number of simultaneous HIV/AIDS diagnosesa Public Health Agency of Sweden 1980–2002 InfCareHIV 2003–2013
Number of deaths in HIV-1 infectedc Public Health Agency of Sweden 1983–1994 InfCareHIV 1995–2013
Median CD4+-count at HIV-1 diagnosis InfCareHIV 1983–2013
Number of people seen for HIV-1 care InfCareHIV 1983–2013
Number of people receiving ART InfCareHIV 1987–2013
Percent of people diagnosed late (CD4+ < 200 
cells/μl)d InfCareHIV 1983–2013
Percent of people diagnosed promptly 
(CD4+ ≥ 350 cells/μl)d InfCareHIV 1983–2013
Percent of people on ART with CD4+ ≥ 350 cells/
μld InfCareHIV 1987–2013
Percent of people on ART with viral load < 500 
copies/ml InfCareHIV 1996–2013
Death rates in the general population The National Board of Health and Welfare 2008
Proportion of HIV-1 infected with HCV/HBV InfCareHIV 2014
Linkage to care InfCareHIV 2013
Retention in care InfCareHIV 2013
Proportion with viral suppression InfCareHIV 2013
AIDS: acquired immunodeficiency syndrome; ART: antiretroviral therapy; HBV: hepatitis B virus; HCV: hepatitis C virus; InfCareHIV: National 
Quality Registry for HIV; SSOPHIE: Stochastic Simulation model of Outcomes of People with HIV In Europe.
a Surveillance reports for AIDS from 1980–84 were reregistered after availability of HIV testing in 1985.
b Possible under-reporting after 2005 is compensated by factoring in 15% in the model.
c For heterosexual migrants from sub-Sahara, data source 1 covered 1988–2006 and data source 2 covered 2007–13.
d CD4+ cell counts in these formats were used only for the whole population.
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that time, 94% of persons on ART had viral loads < 50 
copies/ml (Veronica Svedhem, personal communica-
tion, 22 December 2014).
For both models, estimates for the undiagnosed pro-
portion were made for all PLHIV as well as separately 
for the following transmission groups: men having sex 
with men (MSM), heterosexually infected migrants 
from SSA and other heterosexually infected patients, 
i.e. Swedish-born persons and migrants from other 
areas in the world than SSA. The number of individuals 
in the subpopulations do not add up to the total num-
ber of PLHIV, because not all PLHIV are part of one of 
these three subgroups. People with injecting drug use 
and heterosexually infected migrants from south-east 
Asia are also relevant transmission groups in Sweden, 
but they were too small to model individually.
SSOPHIE
SSOPHIE was developed by Nakagawa et al. within the 
Stochastic Simulation of Outcomes of People with HIV 
In Europe project in EuroCoord (EuroCoord-SSOPHIE 
project) [11-13]. Briefly, the model accounts for domes-
tic and non-domestic infections and uses clinical 
and observational data to simulate hypothetical HIV-
infected individuals from the beginning of a speci-
fied HIV epidemic until the present time. Approximate 
Bayesian computation (ABC) methods are used to 
calibrate the simulated data to the observed data. The 
model was developed for settings where extensive sur-
veillance information is available but is flexible with 
respect to which parameters are required and depend-
ing on data reliability, parameters can be weighted 
and/or fixed. To account for suggested epidemiological 
differences in access to care, diagnosis rate etc. trans-
mission groups can be categorised in order to calibrate 
and obtain estimates for the entire population as well 
as separately for larger subgroups.
Estimates on migration from SSA were included 
in SSOPHIE. We used the approach described by 
Nakagawa et al. [13] Briefly, we simulated a ‘pool’ of 
HIV-positive people living in SSA using Spectrum/
Estimation and Projection Package (EPP) and an HIV-
incidence curve based on UNAIDS estimates [19,20]. 
From this pool, we assumed a rate of migration of HIV-
infected persons based on the national data on migra-
tion from SSA to Sweden, under the assumption that 
HIV-infected and uninfected persons had a similar rate 
of migration. This enabled us to make estimates relat-
ing to the transmission subgroup of heterosexually 
infected migrants from SSA.
SSOPHIE was run on data until 2013 for all PLHIV and 
the subgroups. For the heterosexual transmission 
groups, estimates were produced separately for men 
and women. SSOPHIE estimates are given as point esti-
mates with 90% plausibility ranges (PR) that indicate 
the certainty of the point estimate.
A total of 30,000 simulations were performed, of which 
16,060 were not terminated prematurely; 748 runs 
were under the calibration-score < 0.3 (i.e. they resulted 
in outputs that were quite close to the observed 
data with an average deviation from the observed 
data across all data items < 30%). We aimed for a 
Figure 1
HIV (A) incidence of domestic infections and (B) diagnosis rate in PLHIV, by year, Sweden, 1980–2013
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calibration-score as low as possible given that we were 
attempting to reconcile data from several sources on 
various aspects of the epidemic. We balanced the aim 
for a low calibration-score with the desire to have at 
least 100 parameter sets so that we could consider a 
range of ways in which the epidemic could be recon-
structed. Too few runs (only 17) were under the desired 
threshold of calibration-score < 0.25 and the results 
were therefore based on the 107 parameter sets with 
calibration-score < 0.27. Data items used for calibration 
are shown in Supplementary Table S1 and examples in 
Supplementary Figure S1.
The ECDC HIV Modelling Tool
The incidence method in the ECDC HIV Modelling Tool 
version 1.3.0 is a multi-state back-calculation model 
based on maximum likelihood statistics [14,15]. The 
method first estimates HIV incidence over time and 
time from infection to diagnosis by CD4+ count strata 
and then estimates the size of the HIV-positive popula-
tion. Migration is not addressed in the model but sub-
groups can be analysed separately.
The model included data from 1983 up to 2016 for all 
PLHIV and separately for the subgroups MSM, hetero-
sexual migrants from SSA and other heterosexually 
infected individuals. An optimised model, as assessed 
by the goodness of fit results, was chosen and the 
same settings were used for all subgroups. HIV diag-
noses were modelled from 1985, but the model was 
not fitted to data for 1985 and 1986 to avoid the peak 
of diagnoses reflecting the introduction of HIV-testing. 
Diagnosis rate was differentiated by CD4+ count catego-
ries from 1987 and improvements in fit were obtained 
by increasing the number of knots in the incidence 
curve to six and adjusting the length of time intervals 
(Supplementary Table S2a). Bootstrap analysis (1,000 
iterations) was applied to produce 95% confidence 
intervals (CI) of the estimates from the final model.
Results
SSOPHIE estimates
Using SSOPHIE, we modelled HIV incidence and HIV 
diagnosis rate to estimate the proportion of undiag-
nosed PLHIV. Figure 1a shows that SSOPHIE estimated 
a median incidence of 400–500 new domestic HIV 
infections per year during 2000–13 with an increasing 
90% PR.  Figure 1b  shows that the diagnosis rate was 
estimated to have decreased from the end of the 90s 
until 2013.
The number of undiagnosed individuals among all 
PLHIV during 1980–2013 as estimated by SSOPHIE is 
shown in Figure 2 and the estimates for subgroups are 
summarised in Table 3. The proportion of undiagnosed 
PLHIV was 26% in 2013 (n = 2,100; 90% PR: 900–5,000). 
The estimate of undiagnosed infections was lowest in 
MSM; 17% (n = 600; 90% PR: 100–2,000), and high-
est in heterosexual men from sub-Saharan Africa; 35% 
(n = 300; 90% PR: 200–700). The proportion undiag-
nosed among heterosexually infected persons, exclud-
ing migrants from SSA, was 30% in both men (n = 300; 
90% PR: 100–1,000) and women (n = 400; 90% PR: 
100–1,200).
The ECDC HIV Modelling Tool estimates
The estimates of the HIV incidence and time to diagno-
sis obtained with the ECDC HIV Modelling Tool are pre-
sented in Figure 3. The incidence of HIV infections was 
estimated to have stabilised between 400 and 500 new 
infections per year since 2001 (Figure 3a). However, 
the ECDC model does not account for migration, this 
means that infection could have occurred abroad and 
those foreign-born persons could have been living with 
HIV abroad before being diagnosed in Sweden. The 
time from infection to diagnosis was estimated to have 
gradually increased from under 3 years in the 1980s to 
5 years in 2016 (Figure 3b). Time to diagnosis was high-
est among migrants from SSA, over 6 years since 2011 
and lowest in MSM, 3 to 4 years since 2003 (data not 
shown).
The ECDC model estimates of the proportion of undiag-
nosed PLHIV in 2013 are shown in  Figure 4  and  Table 
3. The overall estimate was 21% (n = 2,013; 95% CI: 
1,831–2,189), with 15% (n = 369; 95% CI: 299–434) 
in MSM, 21% (n = 530; 95% CI: 436–632) in migrants 
from SSA, and 21% (n = 502; 95% CI: 407–600) in other 
heterosexually infected persons. For the ECDC model, 
input data until 2016 were available and used to obtain 
estimated proportions of undiagnosed PLHIV (Table 3). 
The estimate for all PLHIV was 20% (n = 2,107; 95% CI: 
1,688–2,577), in MSM 17% (n = 518; 95% CI: 355–706), 
in migrants from SSA 19% (n = 535; 95% CI: 359–789) 
and in other heterosexually infected persons 22% 
(n = 589; 95% CI: 398–884).
Figure 2
Estimated number of persons living with undiagnosed 
HIV, by year, Sweden, 1980–2013
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Discussion
We found that the estimated proportion of undiagnosed 
PLHIV in Sweden in 2013 was comparable between 
SSOPHIE (26%) and the ECDC model (21%). The ECDC 
model suggested that the proportion of undiagnosed 
was similar in 2016 (20%). Both methods estimated 
around 2,000 individuals living with undiagnosed HIV 
in Sweden. However, the SSOPHIE estimate had a wide 
PR and the ECDC model did not account for migration, 
which makes the accuracy of both estimates uncertain.
The domestic incidence of HIV infections in Sweden 
estimated with SSOPHIE (400–500 infections per year 
during 2000–13) seems unrealistically high given that 
a total of 400–500 new HIV cases (domestic and non-
domestic) per year were reported to the Public Health 
Agency of Sweden during the same time period of 
whom a majority (76% in 2013) were reported to be 
non-domestic [3]. The ECDC model had narrow 95% CI 
when considering the wide PR from SSOPHIE, but did 
not adjust for infections acquired abroad and there-
fore did not take into account that migrant PLHIV only 
contribute to the undiagnosed fraction after arrival 
to Sweden. Consequently, the SSOPHIE and the ECDC 
point estimates should be interpreted with caution.
Based on the preconception regarding the propor-
tion of undiagnosed PLHIV among Swedish epidemi-
ologists and clinicians, both estimates are higher than 
expected. The estimates also exceed the 12–20% undi-
agnosed in 2006 estimated by Hamers et al. utilising 
surveillance data from 2005 and the HIV Synthesis 
Table 3
Proportion and number of undiagnosed PLHIV, as estimated by SSOPHIE and the ECDC HIV Modelling Tool, Sweden, 
2013 and 2016
Transmission group
SSOPHIE 
 
2013
ECDC model  
 
2013
ECDC model  
 
2016
Proportion
n 
 
(90% PR)
Proportion 
 
(95% CI)
n 
 
(95% CI)
Proportion 
 
(95% CI)
n 
 
(95% CI)
All PLHIVa 26% 2,100 (900–5,000) 21% (20–23%) 2,013 (1,831–2,189) 20% (17–23%)
2,107 
(1,688–2,577)
MSM 17% 600 (100–2,000) 15% (12–17%) 369 (299–434) 17% (13–22%) 518 (355–706)
Migrants from SSA 21% (18–24%) 530 (436–632) 19% (14–26%) 535 (359–789)
Male 35% 300 (200–700)
Female 34% 400 (200–800)
Other heterosexual 21% (18–25%) 502 (407–600) 22% (16–30%) 589 (398–884)
Male 30% 300 (100–1,000)
Female 30% 400 (100–1,200)
CI: confidence interval; ECDC: European Centre for Disease Prevention and Control; MSM: men having sex with men; PLHIV: persons living with 
HIV (diagnosed or undiagnosed); PR: plausibility range; SSA: sub-Saharan Africa; SSOPHIE: Stochastic Simulation model of Outcomes of 
People with HIV In Europe.
a The number of individuals in the subpopulations do not add up to the total number of PLHIV, because not all PLHIV are part of one of these 
three subgroups.
Figure 3
HIV (A) incidence and (B) time to diagnosis, by year, Sweden, 1980–2016
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model (a predecessor of SSOPHIE) [10]. In our study, 
both models estimated around 30% undiagnosed infec-
tions in 2006 (data not shown). Neither are the results 
in line with an estimate of 10.8% in 2015 – based on 
advanced modelling on multiple-biomarker estimates 
of time between infection and diagnosis [21].
The point estimates for undiagnosed infections in male 
(35%) and female (34%) migrants from SSA and in other 
individuals with heterosexual transmission (30%) were 
higher in SSOPHIE, but the PRs of SSOPHIE overlapped 
with the 95% CIs of the ECDC estimates, indicating that 
there was no true discrepancy between the results.
Both models predicted that MSM have the lowest pro-
portion of undiagnosed infections. Historically, this 
subpopulation has been less influenced by migration 
making it more suitable for modelling using these 
two methods. However, in 2016, 74% of MSM diag-
nosed with HIV in Sweden were reported to have been 
infected abroad and 71% were born in another coun-
try (data not shown), suggesting that migration is of 
increasing importance also in this group.
Our surveillance data are of high quality, but had some 
limitations; CD4+ cell count medians from the 1980s 
might be slightly biased by incomplete coverage but 
this is unlikely to have affected our results. The ECDC 
HIV Modelling Tool takes missing data into account by 
assuming that CD4+ count data are missing at random 
in individuals with no concurrent AIDS diagnosis. We 
expect some under-reporting of AIDS after 2005 when 
reporting was no longer mandatory. In SSOPHIE, we 
have compensated for this, but in the ECDC model, 
missing data on concurrent HIV/AIDS diagnoses could 
potentially lead to estimates of time from HIV infection 
that are shorter than the true values.
There are several limitations in estimating the pro-
portion of undiagnosed PLHIV in Sweden using these 
two models. First, it is difficult to enumerate a ‘hid-
den’ population on whom we have no direct data. 
Second, the models were applied to small numbers 
with the Swedish HIV epidemic limited to 400–500 
new reported cases per year and even smaller numbers 
for each modelled subgroup. Third, how to properly 
account for migration, as migrants from SSA and other 
areas of the world constitute a large proportion of new 
HIV cases in Sweden. SSOPHIE explicitly attempts to 
account for migration, but as our migration data were 
imprecise the HIV prevalence in SSA and the rate of 
migration from this region to Sweden was used in the 
model; weaknesses in incomplete migration data from 
Sweden and any biases introduced by the assumptions 
on migration of PLHIV from SSA might have affected 
the results. Also, migration was only considered in the 
subgroup heterosexually infected migrants from SSA, 
even though some migrants have other transmission 
routes and origin. The ECDC model does not account 
for migration at all. Fourth, the characteristics of the 
Swedish HIV epidemic have changed substantially 
since the 1980s, with migration becoming an increas-
ingly important factor. Thus, the calibration to his-
torical data in both models may not be have been an 
optimal approach in Sweden. The feasibility of national 
estimates of undiagnosed infections in a country where 
both travel and migration have a large impact on the 
HIV epidemic is dependent on the inclusion of detailed 
travel and migration data in surveillance reporting 
as well as the availability of updated and complete 
national migration data. Modelling approaches for set-
tings with similar patterns of HIV epidemics need to 
consider migration as an important factor. Since no 
method will be perfect, comparisons of results from 
different approaches while understanding their pros 
and cons are important.
In conclusion, there remains uncertainty over the pro-
portion of undiagnosed PLHIV in Sweden and both 
methods used have limitations. Consequently, it is dif-
ficult to properly evaluate the HIV care continuum in 
the country. The main challenges with estimating the 
proportion of undiagnosed PLHIV in Sweden are the 
high proportion of foreign-born PLHIV, a comparably 
small number of new cases per year and heterogeneity 
between subgroups of PLHIV. A combination of better 
input data on migration and updated or new models 
are likely required to address these challenges.
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